FDA Inspection 1292016 — Lelypharma BV
The FDA completed an inspection of Lelypharma BV on September 26, 2025 in Lelystad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 26, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lelystad (Netherlands)